Dr. Seibold is Professor of Internal Medicine and Director of the University of Michigan Scleroderma Program in Ann Arbor, Michigan, USA.

He had been on the faculty of UMDNJ from 1980-2004 where he had served as Chief of the Division of Rheumatology, Director of the Clinical Research Center and as the W.H. Conzen Chair of Clinical Pharmacology. In July 2004, he became Professor and Director of the University of Michigan Scleroderma Program.

Author of more than 300 scientific publications, he is considered a world thought leader in scleroderma, Raynaud's phenomenon and interventional research in the rheumatologic diseases. He has received multiple awards from arthritis and scleroderma patient organizations and appears on virtually every listing of "Best Doctors".

Dr. Seibold wrote the Introduction to Voices of Scleroderma Volume 2, and Voices of Scleroderma Volume 3, which are superb books with top quality medical and support information for patients and caregivers, and published by the International Scleroderma Network (ISN).

Dr. Seibold is currently the President of the Scleroderma Clinical Trials Consortium - a key partner with the ISN in scleroderma clinical research efforts. (See ISN/SCTC Research Fund) .

Dr. Seibold is also a Fellow of the American College of Physicians and a Fellow of the American College of Rheumatology.

James R. Seibold, M.D.
Professor & Director
Marvin and Betty Danto Research Professor
University of Michigan Scleroderma Program
24 Frank Lloyd Wright Drive
PO Box 481, Lobby M
Suite 2500
Ann Arbor, MI 48106-0481
Phone: 734-763-3110
Fax: 734-763-5761

For physicians: james-seibold@sclero.org
For appointment inquiries with Dr. Seibold, please call: 1-734-763-3110.

For your nearest scleroderma center/expert, please see
Scleroderma Experts.

All others, please contact the ISN through our main
email address and hotline numbers. Thank you!